Abstract
Despite the importance of accurate diagnosis of prostate cancer (PC) patients for their appropriate management, the real prevalence of PC statuses is poorly documented. This observational, cross-sectional study aimed to assess the prevalence of castration-resistant PC (CRPC) of unknown metastatic status (CRPC-MX) and describe its clinical management.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
